
Sign up to save your podcasts
Or
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
4.7
16081,608 ratings
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
4,093 Listeners
491 Listeners
3,177 Listeners
828 Listeners
2,190 Listeners
1,367 Listeners
3,368 Listeners
806 Listeners
1,492 Listeners
933 Listeners
2,286 Listeners
586 Listeners
383 Listeners
873 Listeners
1,539 Listeners
399 Listeners
232 Listeners